Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - CYMER INC | d8k.htm |
Exhibit 99.1
| FOR IMMEDIATE RELEASE | ||||
|
Investor Relations Contact: |
Media Contact: | |||
| Natalie Badillo Cymer, Inc. (858) 385-6097 nbadillo@cymer.com |
Erin Coller Formula (619) 234-0345 coller@formulapr.com | |||
CYMER REPORTS FOURTH QUARTER AND 2010 OPERATING RESULTS
SAN DIEGO, Calif., February 2, 2011 - Cymer, Inc. (Nasdaq: CYMI), the world’s leading supplier of light sources used by chipmakers to create advanced semiconductor chips, today announced operating results for the fourth quarter and year ended December 31, 2010.
For the fourth quarter of 2010:
| • | net income totaled $32.9 million, equal to $1.08 per share (diluted), compared to net income of $12.2 million, equal to $0.40 per share (diluted) in the fourth quarter of 2009 and net income of $20.9 million, equal to $0.70 per share (diluted), in the third quarter of 2010. |
| • | revenue totaled $146.9 million compared to revenue of $96.4 million in the fourth quarter of 2009, and revenue of $141.7 million in the third quarter of 2010. |
For the year ended December 31, 2010:
| • | net income totaled $91.0 million equal to $3.02 per share (diluted), compared to net income of $12.0 million, equal to $0.40 per share (diluted) for the year ended December 31, 2009. |
| • | revenue totaled $534.2 million compared to revenue of $307.7 million in the prior year. |
Commenting on results, Bob Akins, Cymer’s chief executive officer, said, “2010 was a year of significant accomplishment and growth for Cymer. The demonstrated performance and reliability of our deep ultraviolet (DUV) light sources were instrumental in winning chipmaker selections and strengthened our competitive position. We also increased our OnPulse value and coverage, while adding advanced performance enhancements on ArF immersion and KrF sources. Our continued focus on operational execution and cost structure improvements, coupled with improved manufacturing absorption contributed to strong margin performance. During 2010, we shipped four extreme ultraviolet (EUV) 3100 sources and installed a second TCZ tool at a second Asian customer. I want to take this time to thank Cymer employees for their dedication and significant achievements in 2010. Their commitment to the success of our customers and their drive towards continued technology leadership further positions Cymer as the leader of lithography light source solutions and an innovator of display fabrication equipment.”
- more -
| CYMER REPORTS FOURTH QUARTER AND 2010 OPERATING RESULTS | Page 2 of 6 |
In the fourth quarter of 2010, the company shipped 35 light sources, of which 26 were ArF immersion, eight were KrF, and one was ArF dry, and the company installed 47 light sources at chipmaker locations. Gross profit was $78.0 million for the fourth quarter of 2010, yielding a 53.1 percent gross margin. Total operating expenses, which include research and development and selling and administrative expenses, were $40.9 million. Total operating income was $37.1 million or 25.3 percent of revenue. With the reinstatement of the R&D tax credit in late December, our full year effective tax rate was 25 percent, which resulted in a fourth quarter effective tax rate of 11 percent.
DUV bookings for the fourth quarter of 2010 totaled $153.2 million, resulting in a book-to-bill ratio of 1.04. Eighty-three percent of the DUV bookings in the fourth quarter were ArF immersion, 13 percent were KrF, and four percent were ArF dry. The company ended the quarter with a DUV backlog of $63.6 million, with ArF immersion light sources comprising approximately 80 percent of the value of sources in backlog.
For the full year 2010, the company shipped 124 light sources, of which 87 were ArF immersion, 35 were KrF, and two were ArF dry. The company reported gross profit of $272.8 million for the full year 2010, yielding a 51.1 percent gross margin. Total operating expenses for the year of $151.7 million includes research and development, selling and administrative and restructuring expenses. Total operating income was $121.1 million or 22.7 percent of revenue.
As of December 31, 2010, cash and investments totaled approximately $217 million, an increase of $31 million from December 31, 2009.
Company Outlook
Commenting on the outlook, Akins stated, “We believe we are well positioned for growth in 2011. Our attention to light source reliability, customer productivity, and cost of operations have resulted in several recent key light source selections from chipmakers, some of whom have recently announced significant increases to their 2011 capex plans. We believe this increase in capex investment will translate into continued growth as the year proceeds. We are continuing to invest in EUV and will be highly focused on the development of our EUV 3300 sources. In TCZ, we are focused on ramping our manufacturing capability to fulfill recently received orders.”
Based on information available at this time, Cymer is providing the following guidance for the first quarter of 2011:
| • | Revenue to be approximately $150 million. |
| • | Gross margin to be approximately 50 percent. |
| • | R&D expenses to be approximately $27 million. |
| • | SG&A expenses to be approximately $16.5 million. |
| • | The effective tax rate to be approximately 22 percent. |
Cymer’s management will hold a conference call at 2:00 pm (PST) today, February 2, 2011, to discuss fourth quarter and 2010 operating results and first quarter 2011 guidance. This press release, the conference call and accompanying slides may be accessed on the investor relations page of the company’s Web site at www.cymer.com.
- more -
| CYMER REPORTS FOURTH QUARTER AND 2010 OPERATING RESULTS | Page 3 of 6 |
Forward Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to statements regarding the company’s competitive position, continued technology leadership, the company’s positioning, the industry’s transition to EUV lithography and the statements under the caption “Company Outlook” above. These statements are predictions based on current information and expectations and involve a number of risks and uncertainties. In addition, statements regarding backlog and book-to-bill ratios should not be read as predictions or projections of future performance. Actual events or results may differ materially from those projected in any of such statements due to various factors, including but not limited to: the demand for semiconductors in general, and, in particular, for leading-edge devices with smaller geometries; cyclicality in the market for semiconductor manufacturing equipment; the timing of customer orders, shipments and acceptances; delays or cancellations by customers of their orders; the performance and market acceptance of the company’s new products or technologies; new and enhanced product offerings by competitors; the company’s ability to meet its production and product development schedules; the rate at which semiconductor manufacturers adopt new technologies and purchase and take delivery of photolithography tools from the company’s customers; the company’s ability to secure adequate supplies of critical components for its advanced products; the company’s ability to manage its expense levels and unanticipated expenses; the company’s ability to achieve its forecasted gross margin which includes its ability to absorb manufacturing costs; the company’s ability to align its cost structure with forecasted business levels; the company’s ability to manage its foreign currency exposure; the performance and conditions in the United States and world financial markets; the policies and actions of the United States and other governments; and general economic conditions. For a discussion of these and other factors which may cause our actual events or results to differ from those projected, please refer to the company’s most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission (SEC). You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
About Cymer
Cymer, Inc. (Nasdaq: CYMI) is the market leader in developing light sources, used by chipmakers worldwide to pattern advanced semiconductor chips, and is pioneering a new silicon crystallization tool for the flat panel display industry. Cymer’s light sources have been widely adopted by the world’s top chipmakers and the company’s installed base comprises approximately 3,500 systems. Continuing its legacy of leadership, Cymer is currently pioneering the industry’s transition to EUV lithography, the next viable step on the technology roadmap for the creation of smaller, faster chips. The company is headquartered in San Diego, Calif., and supports its customers from numerous offices around the globe. Cymer maintains a Web site to which it regularly posts press releases, SEC filings, and additional information about Cymer. Interested persons can also subscribe to automated e-mail alerts or RSS feeds. Please visit www.cymer.com.
Cymer and all other Cymer product or service names used herein are either registered trademarks or trademarks of Cymer, Inc. Any other marks mentioned herein are the property of their respective holders.
- more -
| CYMER REPORTS FOURTH QUARTER AND 2010 OPERATING RESULTS | Page 4 of 6 |
CYMER, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(in thousands, except per share data)
| Three Months Ended December 31, |
Years Ended December 31, |
|||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
| Revenues: |
||||||||||||||||
| Product sales |
$ | 146,854 | $ | 96,071 | $ | 534,209 | $ | 306,795 | ||||||||
| Product sales, related party |
— | 333 | — | 869 | ||||||||||||
| Total revenues |
146,854 | 96,404 | 534,209 | 307,664 | ||||||||||||
| Cost of revenues |
68,859 | 50,154 | 261,442 | 171,250 | ||||||||||||
| Gross profit |
77,995 | 46,250 | 272,767 | 136,414 | ||||||||||||
| Operating expenses: |
||||||||||||||||
| Research and development |
25,043 | 15,823 | 89,193 | 65,809 | ||||||||||||
| Sales and marketing |
5,464 | 4,019 | 22,656 | 16,603 | ||||||||||||
| General and administrative |
10,352 | 6,730 | 39,802 | 27,569 | ||||||||||||
| Restructuring |
— | — | — | 8,407 | ||||||||||||
| Total operating expenses |
40,859 | 26,572 | 151,651 | 118,388 | ||||||||||||
| Operating income |
37,136 | 19,678 | 121,116 | 18,026 | ||||||||||||
| Other income (expense): |
||||||||||||||||
| Foreign currency exchange gain (loss) |
11 | 381 | (6 | ) | (1,107 | ) | ||||||||||
| Impairment of investments |
— | — | — | (291 | ) | |||||||||||
| Interest income |
132 | 166 | 524 | 1,374 | ||||||||||||
| Interest expense |
(189 | ) | (108 | ) | (605 | ) | (1,029 | ) | ||||||||
| Other income (expense) |
9 | — | 55 | 135 | ||||||||||||
| Total other income (expense) |
(37 | ) | 439 | (32 | ) | (918 | ) | |||||||||
| Income before income taxes |
37,099 | 20,117 | 121,084 | 17,108 | ||||||||||||
| Income tax expense |
4,236 | 9,021 | 30,271 | 8,389 | ||||||||||||
| Net income |
$ | 32,863 | $ | 11,096 | $ | 90,813 | $ | 8,719 | ||||||||
| Net loss attributable to noncontrolling interest in subsidiary |
— | 1,057 | 148 | 3,257 | ||||||||||||
| Net income attributable to Cymer, Inc. |
$ | 32,863 | $ | 12,153 | $ | 90,961 | $ | 11,976 | ||||||||
| Earnings per share: |
||||||||||||||||
| Basic |
$ | 1.11 | $ | 0.41 | $ | 3.05 | $ | 0.40 | ||||||||
| Diluted |
$ | 1.08 | $ | 0.40 | $ | 3.02 | $ | 0.40 | ||||||||
| Weighted average shares outstanding: |
||||||||||||||||
| Basic |
29,710 | 29,861 | 29,777 | 29,738 | ||||||||||||
| Diluted |
30,351 | 30,264 | 30,124 | 29,945 | ||||||||||||
- more -
| CYMER REPORTS FOURTH QUARTER AND 2010 OPERATING RESULTS | Page 5 of 6 |
CYMER, INC.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in thousands, except share data)
| December 31, | ||||||||
| 2010 | 2009 | |||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 154,312 | $ | 118,381 | ||||
| Restricted cash |
— | 1,200 | ||||||
| Short-term investments |
54,964 | 62,895 | ||||||
| Accounts receivable, net |
127,747 | 76,792 | ||||||
| Accounts receivable, related party |
— | 732 | ||||||
| Inventories |
213,002 | 185,077 | ||||||
| Deferred income taxes |
11,961 | 31,566 | ||||||
| Other current assets |
55,027 | 26,244 | ||||||
| Total current assets |
617,013 | 502,887 | ||||||
| Long-term investments |
7,506 | 5,167 | ||||||
| Property and equipment, net |
104,705 | 106,755 | ||||||
| Deferred income taxes |
35,690 | 26,998 | ||||||
| Goodwill |
8,833 | 8,833 | ||||||
| Intangible assets, net |
7,645 | 8,327 | ||||||
| Other assets |
5,939 | 5,951 | ||||||
| Total assets |
$ | 787,331 | $ | 664,918 | ||||
| LIABILITIES |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 27,731 | $ | 21,756 | ||||
| Accounts payable, related party |
— | 9,284 | ||||||
| Deferred revenue |
30,593 | 22,339 | ||||||
| Other current liabilities |
68,121 | 50,244 | ||||||
| Total current liabilities |
126,445 | 103,623 | ||||||
| Deferred revenue |
690 | 525 | ||||||
| Deferred income taxes |
21 | 18 | ||||||
| Other liabilities |
21,920 | 19,114 | ||||||
| Total liabilities |
149,076 | 123,280 | ||||||
| EQUITY |
||||||||
| Cymer, Inc. stockholders’ equity: |
||||||||
| Preferred stock |
— | — | ||||||
| Common stock |
43 | 43 | ||||||
| Additional paid-in capital |
620,272 | 598,314 | ||||||
| Treasury stock |
(492,890 | ) | (473,580 | ) | ||||
| Accumulated other comprehensive loss |
(2,881 | ) | (8,280 | ) | ||||
| Retained earnings |
513,711 | 422,750 | ||||||
| Equity attributable to Cymer, Inc. |
638,255 | 539,247 | ||||||
| Noncontrolling interest |
— | 2,391 | ||||||
| Total equity |
638,255 | 541,638 | ||||||
| Total liabilities and equity |
$ | 787,331 | $ | 664,918 | ||||
- more -
| CYMER REPORTS FOURTH QUARTER AND 2010 OPERATING RESULTS | Page 6 of 6 |
CYMER, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
| Years Ended December 31, | ||||||||
| 2010 | 2009 | |||||||
| Operating activities: |
||||||||
| Net income |
$ | 90,813 | $ | 8,719 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
| Depreciation, amortization and accretion |
19,223 | 21,057 | ||||||
| Stock-based compensation |
10,603 | 5,667 | ||||||
| Bad debt expense |
(843 | ) | 2 | |||||
| Excess tax benefits from stock option exercises |
(2,087 | ) | (267 | ) | ||||
| Provision for deferred income taxes |
12,755 | (634 | ) | |||||
| Loss on disposal or impairment of property and equipment |
609 | 1,881 | ||||||
| Write-down of investments |
— | 291 | ||||||
| Change in assets and liabilities: |
||||||||
| Restricted cash |
1,235 | (1,200 | ) | |||||
| Accounts receivable |
(48,659 | ) | (12,651 | ) | ||||
| Accounts receivable, related party |
732 | 86 | ||||||
| Inventories |
(30,698 | ) | 4,361 | |||||
| Other assets |
(27,947 | ) | (2,684 | ) | ||||
| Accounts payable |
7,976 | 5,429 | ||||||
| Accounts payable, related party |
(9,284 | ) | 3,876 | |||||
| Deferred revenue |
8,665 | 7,379 | ||||||
| Other liabilities |
21,395 | (7,053 | ) | |||||
| Net cash provided by operating activities |
54,488 | 34,259 | ||||||
| Investing activities: |
||||||||
| Acquisition of property and equipment |
(15,810 | ) | (7,208 | ) | ||||
| Purchases of investments |
(100,056 | ) | (94,161 | ) | ||||
| Proceeds from sold or matured investments |
105,211 | 65,909 | ||||||
| Net cash used in investing activities |
(10,655 | ) | (35,460 | ) | ||||
| Financing activities: |
||||||||
| Proceeds from issuance of common stock |
9,446 | 6,744 | ||||||
| Purchase of noncontrolling interest |
(2,186 | ) | — | |||||
| Repayment of convertible subordinated note |
— | (140,722 | ) | |||||
| Cash investment in joint venture received from minority shareholder |
— | 800 | ||||||
| Excess tax benefits from stock option exercises |
2,087 | 267 | ||||||
| Repurchase of common stock into treasury |
(19,310 | ) | — | |||||
| Net cash used in financing activities |
(9,963 | ) | (132,911 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents |
2,061 | 102 | ||||||
| Net increase (decrease) in cash and cash equivalents |
35,931 | (134,010 | ) | |||||
| Cash and cash equivalents at beginning of the year |
118,381 | 252,391 | ||||||
| Cash and cash equivalents at end of the year |
$ | 154,312 | $ | 118,381 | ||||
| Supplemental disclosure of cash flow information: |
||||||||
| Interest paid |
$ | 405 | $ | 2,803 | ||||
| Income taxes paid |
$ | 42,295 | $ | 11,232 | ||||
| Supplemental disclosure of non cash operating, investing and financing activities: |
||||||||
| Net (decrease) increase in acquisition of property and equipment included in accounts payable |
($ | 1,774 | ) | $ | 2,497 | |||
| Net (decrease) increase in in-transit proceeds from issuance of common stock |
($ | 11 | ) | $ | 81 | |||
| Property and equipment acquired under capital lease obligations |
$ | 136 | — | |||||
###